Revitalizing the Therapeutic Pipeline for C. difficile Infection through Nonantimicrobial and Host-Directed Strategies

Abstract Clostridioides difficile infection (CDI) remains a leading cause of healthcare-associated diarrhea, arising largely from antimicrobial-induced displacement of the gut microbiota. Although antimicrobial therapy remains the clinical standard for CDI, high rates of recurrence, the spread of antimicrobial-resistant strains, and inadequate interventions for countering toxin-mediated tissue damage highlight the need for alternative strategies. In this review, we evaluate emerging nonantimicrobial approaches for CDI, focusing on microbial-derived metabolites (including short-chain fatty acids and bile acids), plant-derived phytochemicals, and host-directed therapeutics that modulate inflammatory and neuroimmune pathways. Mechanistic insights into how these strategies mitigate C. difficile pathogenesis are also examined, including roles in attenuating intestinal inflammation and preserving epithelial barrier function. Given the multifactorial nature of CDI, we propose there is a need to advance a new therapeutic framework that integrates narrow-spectrum antimicrobials with nonantimicrobial host-directed modalities. Collectively, this conceptual framework provides a rational foundation for developing next-generation interventions for CDI in an era characterized by multidrug resistance and aging populations with comorbidities that are risk factors for CDI.

Authors

Institutions

Publication Details

Journal
ACS Infectious Diseases
Published
2026-11-13
DOI
https://doi.org/10.1021/acsinfecdis.6c00683
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Revitalizing the Therapeutic Pipeline for C. difficile Infection through Nonantimicrobial and Host-Directed Strategies

Julian Gregston Hurdle, Mindy A. Engevik, Wei Zhao
1 links
ACS Infectious Diseases
Clostridium difficile and Clostridium perfringens research
article

Revitalizing the Therapeutic Pipeline for C. difficile Infection through Nonantimicrobial and Host-Directed Strategies

Julian Gregston Hurdle, Mindy A. Engevik, Wei Zhao
article en

Abstract

Abstract Clostridioides difficile infection (CDI) remains a leading cause of healthcare-associated diarrhea, arising largely from antimicrobial-induced displacement of the gut microbiota. Although antimicrobial therapy remains the clinical standard for CDI, high rates of recurrence, the spread of antimicrobial-resistant strains, and inadequate interventions for countering toxin-mediated tissue damage highlight the need for alternative strategies. In this review, we evaluate emerging nonantimicrobial approaches for CDI, focusing on microbial-derived metabolites (including short-chain fatty acids and bile acids), plant-derived phytochemicals, and host-directed therapeutics that modulate inflammatory and neuroimmune pathways. Mechanistic insights into how these strategies mitigate C. difficile pathogenesis are also examined, including roles in attenuating intestinal inflammation and preserving epithelial barrier function. Given the multifactorial nature of CDI, we propose there is a need to advance a new therapeutic framework that integrates narrow-spectrum antimicrobials with nonantimicrobial host-directed modalities. Collectively, this conceptual framework provides a rational foundation for developing next-generation interventions for CDI in an era characterized by multidrug resistance and aging populations with comorbidities that are risk factors for CDI.

ACS Infectious Diseases
Texas A&M Health Science Center (US), Medical University of South Carolina (US)
Good health and well-being
Clostridium difficile and Clostridium perfringens research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon